The number of COVID-19 clinical trials is continually growing, with Europe and the US now in the driver’s seat. here is our second weekly newsletter, with a special focus on the most studied drug so far, hydroxychloroquine.
Copyright CEPTON and INATO
COVIDNews CEPTON-INATO #2
CEPTON Strategies news
Here are all the reports and analysis we published along with the press articles about us
CEPTON is the author of many publications in the field of healthcare and pharmaceuticals and our partners are often interviewed by the specialized press.
Contact us
You have a question, an issue you would like to share with us
Feel free to contact us to arrange a meeting or a teleconference, using the form below.
You would like to apply for a job with us
We are always happy to welcome new profiles in our teams, please fill the following form to apply for a job in CEPTON.
